IDiyas

For the Inventor, By the Inventor

Upper Saddle River, NJ, United States of America

Robert E Schaub

USPTO Granted Patents = 57 

Average Co-Inventor Count = 3.1

ph-index = 9

Forward Citations = 295(Granted Patents)

Forward Citations (Not Self Cited) = 249(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Upper Saddle River, NY (US) (1979)
  • Saddle River, NJ (US) (1993)
  • Upper Saddle River, NJ (US) (1976 - 1995)

Company Filing History:

goldMedal57 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1976-1995

Loading Chart...
57 patents (USPTO):Explore Patents
1. 5411983 - Certain hyrdoxy-phosphinyl-oxy-phenylmethyl-imidazolium hydroxide inner (1995-05-02),
2. 5328901 - Bis-arylphosphate ester antagonists of platelet activating factor (1994-07-12),
3. 5234918 - Certain phosphinyl-oxy-phenyl-methyl-pyridinium-hydroxide inner salts (1993-08-10),
4. 5231091 - Bis-arylphosphate ester antagonists of platelet activating factor (1993-07-27),
5. 5215975 - Certain hydroxy-phosphinyl-oxy-phenyl methyl-thiazolium hydroxide inner (1993-06-01),
6. 5208223 - Phosphocholine derivative inhibitors of phospholipase A.sub.2 (1993-05-04),
7. 5147864 - Bis-arylphosphate ester antagonists of platelet activating factor (1992-09-15),
8. 5144045 - Phosphocholine derivative inhibitors of phospholipase A.sub.2 (1992-09-01),
9. 4983592 - Bis-arylphosphate ester antagonists of platelet activating factor (1991-01-08),
10. 4981989 - Antihypertensive phosphate derivatives and intermediates thereof (1991-01-01),
11. 4900731 - Antihypertensive phosphate derivatives (1990-02-13),
12. 4894367 - Antihypertensive phosphate derivatives (1990-01-16),
13. 4883816 - Antihypertensive derivatives (1989-11-28),
14. 4827011 - Antihypertensive phosphate derivatives (1989-05-02),
15. 4762942 - Antihypertensive phosphate derivatives (1988-08-09),

Title: The Inventive Journey of Robert E. Schaub

Introduction:

Robert E. Schaub, a prolific inventor based in Upper Saddle River, NJ, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 57 patents.

Latest Patents:

Among his latest patents is the creation of certain hydroxy-phosphinyl-oxy-phenylmethyl-imidazolium hydroxide inner compounds. These compounds exhibit unique enantiomers, making them valuable in pharmaceutical research. Additionally, Schaub has developed bis-arylphosphate ester antagonists of platelet-activating factor, which hold promise in combating various health conditions.

Career Highlights:

Robert E. Schaub is associated with the American Cyanamid Company, where his innovative spirit thrives. His tenure at the company has been marked by groundbreaking inventions that have the potential to revolutionize the pharmaceutical industry.

Collaborations:

Schaub has notably collaborated with esteemed coworkers such as Martin J. Weiss and Allan Wissner. Their teamwork has led to the successful development and patenting of novel pharmaceutical compounds, showcasing the power of collaboration in the world of inventions.

Conclusion:

In conclusion, Robert E. Schaub's remarkable journey as an inventor underscores his dedication to pushing the boundaries of pharmaceutical innovation. With a wealth of patents to his name and a spirit of collaboration, Schaub continues to shape the future of the industry with his groundbreaking inventions.

(Note: This is a hypothetical article based on the information provided. Robert E. Schaub may be a fictional character.)

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…